Congress moves to break up pharmacy-insurer conflicts in federal employee health plans
H.R. 4409 — Fair Pharmacies for Federal Employees Act of 2025 · Filed by Raja Krishnamoorthi (D-IL) · 2 cosponsors · Introduced Jul 15, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill prohibits the Office of Personnel Management from contracting with health insurance carriers for federal employee health plans if those carriers own or control pharmacies or pharmacy benefit managers (PBMs), and prohibits PBMs contracted by federal health plans from owning pharmacies. The goal is to eliminate conflicts of interest where a single company profits from both setting drug prices (as a PBM) and dispensing drugs (as a pharmacy owner), which can inflate costs for federal employees and taxpayers.
Why we flagged it
The bill's core mechanism is a structural prohibition on vertical integration (common ownership) between health insurers, PBMs, and pharmacies in the federal employee health plan market. It is a straightforward antitrust/conflict-of-interest measure, not a subsidy, deregulation, or commemorative act.
What the text implies
- The bill may force existing integrated carriers (e.g., UnitedHealth, Aetna/CVS) to divest pharmacy or PBM operations or exit the federal employee market entirely, potentially reducing plan options available to federal workers.
- Enforcement depends on OPM's contract-review capacity and willingness to challenge incumbent carriers; weak enforcement could render the prohibition symbolic.
The full analysis lists 5 implications of this text.
Who stands to gain
Independent pharmacy networks and retail pharmacies (reduced competition from integrated PBM-owned c; Federal employees (lower out-of-pocket drug costs if PBM conflicts are eliminated); Taxpayers (lower federal health plan premiums if drug costs decline)